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ABSTRACT 
Diabetes mellitus is a silent killer doing away with one person every 10 seconds. We speak of 
diabetes when the organism cannot control the right level of glucose in the blood. The hormones 
insulin and glucagon secreted by the islets of Langerhans are the major players maintaining glucose 
homeostasis. In the living organism, the function of the islets is orchestrated by their interaction with 
other organs through the vasculature and with the nervous system.  Most of our current knowledge of 
islet biology has been obtained by using mouse models, but caution is needed, as mice are not simply 
small humans. Indeed, recent studies have revealed that the cell composition and architecture of the 
human islet are different from that of mouse islets. Thus, other important features such as nervous 
regulation of islet function may also be different. 
The work in this thesis aimed to identify the role of innervation for islet function. Our 
hypothesis is that autonomic and paracrine signals are involved in islet function and that the relative 
role of these components varies among species. To identify the sympathetic and parasympathetic 
components of innervation as well as their cellular targets we used immunohistochemical staining of 
human and mouse pancreatic sections. In contrast to mouse, human islets are devoid of 
parasympathetic innervation. Instead, human alpha cells possess the machinery for exocytosis of 
acetylcholine, the major parasympathetic neurotransmitter. Our findings suggest that human islets 
depend less on neural cholinergic input than mouse islets. Alpha cells secrete acetylcholine as a 
paracrine signal priming the human beta cell to respond optimally to subsequent increases in glucose 
concentration. In addition, noradrenergic fibers contact few endocrine cells in the human islet and 
preferentially innervate smooth muscle cells of the islet vasculature. This suggests that sympathetic 
innervation regulates hormone secretion by controlling the blood flow rather than modulating 
endocrine cell function directly. 
By taking advantage of our recently developed noninvasive anterior chamber of the eye 
imaging platform we were able to study the role of innervation in the maintenance of glucose 
homeostasis in vivo. We studied the process of reinnervation and revascularization of intraocular islet 
grafts and showed that islets orchestrate the process of engraftment to restore their original 
microenvironment. Islet grafts from two different mouse strains and human xenografts showed 
innervation patterns similar to those in pancreatic sections in situ. Islet grafts displayed the 
characteristic fenestrae of the pancreatic vascular endothelium independently of the origin of the new 
vessels. In addition, the model allowed controlling the fraction of the graft vasculature that is 
contributed by the donor islet endothelial cells to the point that the original donor vasculature of the 
islet is restored. Recording graft function while manipulating the eye’s neural input through the 
pupillary light reflex revealed functional differences in parasympathetic innervation between the two 
mouse strains. The eye platform also allowed us to follow cell dynamics during immune responses, 
which will enable investigations aimed at clarifying the role of innervation in the pathogenesis of 
autoimmune diabetes.  
To study human islet biology in vivo we further adopted the eye model by transplanting 
human islets into the eye of diabetic immune compromised mice. Human xenografts reversed 
diabetes and tightly controlled plasma glucose concentrations. Moreover, our results provided the 
first real time monitoring of revascularization and blood flow inside human islets and graft function 
could be modulated by local drug administration. Our findings establish a “humanized” mouse model 
to investigate human islet biology in vivo that will allow addressing how nervous input affects 
endocrine function or blood flow in human islets. The physiological relevance of the anterior 
chamber of the eye model is further underscored by the therapeutic potential as a novel 
transplantation site to treat type 1 diabetic patients. 
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

A well functioning endocrine pancreas, the islets of Langerhans, is crucial for survival. 
The hormonal secretory activity of pancreatic islets efficiently maintains constant 
levels of plasma glucose. A failure to do so leads to potentially life-threatening 
fluctuations in plasma glucose levels. Dysfunction or death of the insulin-secreting 
beta cells is a major cause of diabetes mellitus, a devastating disease affecting millions 
worldwide. Understanding the biology of the islets of Langerhans is crucial for any 
type of therapy for diabetes mellitus. A great deal is known about the physiology of 
isolated rodent islets because several physiological parameters can be readily recorded.  
The signal transduction pathways that lead from glucose stimulation to insulin 
secretion in beta cells have been dissected out in great detail.  Unfortunately, it is not 
well known how human islets behave, either in their native environment or after 
transplantation, a procedure intended to cure type 1 diabetes mellitus.  It is possible 
that the biology of human pancreatic endocrine cells in vascularized and innervated 
islets differs from that observed in mice.  
 
A close relationship between the nervous system and the regulation of plasma glucose 
was revealed early by Claude Bernard1; Paul Langerhans then recognized a rich 
innervation of the islets since their discovery2. Many studies have implicated the 
autonomic nervous system in metabolic control and islet function3-7. However, the 
importance of the autonomic innervation of the islets in the maintenance of glucose 
homeostasis remains controversial since it has been impossible to discern the effects 
autonomic fibers have specifically on islet cell physiology from those on many other 
organs. Because of these limitations, the relative role of innervation in islet hormone 
secretion has been a matter of a long-standing debate.  There is strong evidence that 
autonomic activation plays a major role in several animal species, but it is unclear 
whether this is the case in humans.  Without this knowledge, the model for the 
regulation of glucose homeostasis is incomplete. 

Based on numerous studies, the endocrine pancreas is richly innervated by the 
autonomic nervous system3-7. Parasympathetic and sympathetic nerves travel to the 
islet through the neurovascular stalk. Within the islets, the nerves follow the blood 
vessels and terminate within the pericapillary space, within the capillary basement 
membrane, or closely apposed to the endocrine cells8. Autonomic axons innervating 
endocrine cells do not display structural features of classical synapses such as synaptic 
clefts or postsynaptic densities but rather have release sites near islet cells. It has been 
proposed that neurotransmitters are released into the interstitial space to affect a group 
of adjacent islet cells. The distribution and density of the different types of nerve fibers 
have been examined in several species. A dense sympathetic innervation, as identified 
by the presence of catecholamine-forming enzymes, has been reported in rodents, 
dogs, and cats9-12. Studies based on the cholinesterase technique have revealed 
parasympathetic innervation in the cat, rat, and rabbit13-16. Fibers containing 
neuropeptides have also been reported, but it is unclear whether these represent unique 
fiber populations or whether these peptides are localized in the autonomic fibers11. In 
  2
addition, there is a network of sensory fibers containing calcitonin gene-related peptide 
(CGRP) and substance P neuropeptides. Thus far, the innervation of human islets has 
been the subject of only a few studies17-19. 
 
Several neurotransmitter receptors are expressed on the plasma membrane of islet 
cells. Activation of M3 muscarinic receptors stimulates insulin and glucagon 
secretion20-22. Release of Ca2+ from intracellular stores in response to muscarinic 
receptor activation has an important role for the insulinotropic action, but the signaling 
underlying the enhanced glucagon secretion is still unknown. Activation of alpha2-
adrenergic receptors inhibits glucose-induced insulin secretion via hyperpolarization of 
the beta cell. Activation of beta2-adrenergic receptors stimulates insulin and glucagon 
secretion. Thus, the actions of a neurotransmitter vary according to the activated 
receptor type. To add to this complexity, neuropeptides, including VIP, NPY, and, in 
some species, galanin also have effects on islet cells5,23-27.  
 
The precise organization of islet innervation is still unknown. Only a few markers have 
been used, and because these markers have not been combined in immunofluorescence 
studies, it is unclear how the different fiber systems relate to each other. For instance, 
it is not known whether the patterns of the parasympathetic and sympathetic 
innervation are complementary or if they overlap in specific regions of the islet. There 
have been few attempts to identify peptides as co-transmitters in cholinergic and 
adrenergic fibers. Furthermore, relying on the cholinesterase technique may be 
misleading because esterases do not map exclusively to parasympathetic nerves. Other 
important prototypical cholinergic markers for the parasympathetic system (e.g. 
ChAT, vAChT) have not been examined. There are no systematic analyses on how and 
where the fibers terminate within the islets, and what particular cells they innervate. It 
is further noteworthy that our current view of islet innervation is mainly based on 
rodent studies, and that, given their unique cytoarchitecture, the situation in human 
islets may be very different28,29.  
 
The overall effect of parasympathetic stimulation is an increase in insulin 
secretion15,16,30-33. Several studies support the view that acetylcholine is released to 
stimulate insulin secretion. Exogenous treatment with acetylcholine or other 
muscarinic agonists stimulates insulin secretion in vivo. This effect can be blocked 
with the muscarinic antagonist atropine15,16. In vivo studies in dogs and baboons 
reported that stimulation of the vagus nerve increases insulin secretion30-32 but this 
stimulation also increases the secretion of other islet hormones such as glucagon, 
somatostatin, and pancreatic polypeptide15,34,35.  
 
The net effect of sympathetic nerve stimulation seems to be a lowering in plasma 
insulin concentration. Exogenous treatment with catecholamines and electrical 
activation of sympathetic nerves inhibits insulin secretion in vivo34,36-38. Alpha-
adrenergic receptor blockade counteracts this inhibition of insulin secretion37,39, 
suggesting noradrenaline as the mediator. However, several other direct and indirect 
mechanisms could contribute to the effects of noradrenaline on insulin secretion. 
Noradrenaline may activate beta-adrenergic receptors on beta cells and adrenergic 
receptors on alpha cells. This makes it difficult to interpret the results. Moreover, this 
effect cannot be attributed solely to the release of noradrenaline from nerve fibers 
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close to beta cells because other tissues innervated by the activated nerves are also 
stimulated. The sympathetic nervous system further exerts profound effects on the 
secretion of the other islet hormones. Splanchnic nerve stimulation and noradrenaline 
application increases glucagon secretion and decreases somatostatin secretion35,37,39-43. 
To our knowledge, similar studies have not been performed in human beings.  
 
In addition to the parasympathetic and sympathetic efferent fibers, a network of 
autonomic afferent sensory fibers also innervates the islets. These fibers leave the 
pancreas along the sympathetic fibers within the splanchnic nerves and transmit 
information about noxious stimuli. Fibers containing the sensory neuropeptides CGRP 
and substance P have been observed in the endocrine pancreas. Vanilloid receptors are 
localized in sensory fibers and generally report pain information. Whether these fibers 
are involved in the regulation of islet hormone secretion remains to be determined. 
Intriguingly, recent papers suggest that molecular defects in the pancreatic sensory 
innervation dramatically affect autoimmune diabetes in NOD mice44,45. These studies 
raise the possibility that signals derived from the nervous system can alter 
inflammation and insulin resistance and thus indirectly affect the development of 
autoimmunity. It is unclear, however, to which extent human islets are innervated by 
sensory fibers. Finding out which receptors are expressed on these fibers is crucial to 
be able to propose that a similar mechanism provides a link between the nervous 
system and autoimmunity in the natural history of type 1 diabetes in human beings.  


Many physiological events under parasympathetic and sympathetic control can 
indirectly interfere with insulin or glucagon secretion. It has been difficult to discern 
the direct effects of autonomic terminals in the islet from the confounding effects of 
the autonomic nervous system elsewhere (e.g. incretin secretion and activation of the 
adrenal medulla). Selective stimulation of islet innervation is difficult. For instance, to 
achieve a specific activation of the pancreas, investigators have to use electrical 
activation of the mixed autonomic nerves along a pancreatic artery with a concomitant 
blockade of the joint preganglionic cholinergic nerves37,43. Furthermore, if not applied 
locally, exogenous application of neurotransmitters can influence multiple organs and 
tissues and, as a result, the effects are the sum of a multitude of activities. An 
additional limitation is that islet cell responses to nerve stimulation in vivo can only be 
measured indirectly in the systemic circulation (e.g. hormone plasma levels). It is not 
possible to record receptor activation directly in the postsynaptic cells.  
 
Although several studies suggest the involvement of islet innervation, the importance 
of the autonomic nervous system in regulating islet hormone secretion is unclear. The 
list of neurotransmitters that may modulate islet function is long and confusing 
because of species differences and uncertainty about the physiological relevance of the 
effects observed with in vivo models. In human subjects, for instance, decreased 
glucose tolerance after vagotomy has been reported46,47, but patients who have 
undergone pancreas transplantation (and thus may have denervated islets) remain 
euglycemic without therapy48-50. For the same reason, there are doubts about whether 
the sympathetic nerve fibers exert a major influence on the basal and postprandial 
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In the early 1870s, van Dooremaal made the extraordinary observation that tumor cells 
injected into the eye formed progressively growing tumors68.  Since then, the eye has 
been widely used as a transplantation site to study the biology of several tissues.  
Ovaries have been transplanted into the anterior eye chamber to study the physiology 
of ovulation69,70 and a wide variety of peripheral and central nervous tissues have been 
shown to proliferate and mature histologically after intraocular transplantation71,72.  
This site has also been extensively used to study the survival and growth of pancreatic 
tissue grafts73,74.  Human xenografts survive in the eye of athymic nude rodents, where 
they become strongly and appropriately innervated72,75-77. 
 
The main advantage of the anterior chamber of the eye over other transplantation sites 
is that biological phenomena can be monitored repeatedly and noninvasively by in vivo 
microscopy because the cornea is transparent.  The grafts might be easily vascularized 
and innervated owing to the rich blood and nerve supply of the iris that forms the bed 
of the anterior chamber of the eye.  Noradrenergic and cholinergic nerve fibers in the 
iris control pupillary diameter.  These fibers have been shown to invade the intraocular 
grafts and can be specifically activated by changing the illumination71 or by topical 
drug administration.  Therefore, autonomic input on the grafted tissue can be 
modulated noninvasively and locally, providing an ideal tool for the study of islet 
function.   

Ultimately, an important question to be addressed is whether intraocular islet grafts 
would restore their native morphology and physiology after transplantation in the eye. 
To pursue the use of intraocular grafts as experimental platform for islet functional 
studies we will need to demonstrate that islets recreate their native environment after 
transplantation. The intra- and inter-species differences with respect to islet 
architecture and functional regulation add more challenges to the model28,29,78. Among 
the complex biological processes following islet engraftment, revascularization and 
reinnervation processes are best described. Pancreatic islet innervation and vasculature 
greatly differ among species78-80 and even strains (unpublished data). Such features 
need to be mimicked in any experimental platform to study islet function and, more 
specifically, to study the role of innervation in vivo, a main goal in this thesis. 
 
Some studies have described the process of islet reinnervation after transplantation in 
different tissues81-83, including the eye84. Islet graft innervation patterns in different 
transplantation sites seem to differ only slightly from that of islets in the pancreas81,83. 
The host tissues seem mainly to determine the reinnervation density of the islet grafts, 
while islets establish their own pattern of innervation after transplantation82. 
Considering the innervation density of the iris, reinnervated intraocular islet grafts 
might be the ideal tools to study the role of innervation in islet function in vivo.  
Intraislet blood flow can be regulated by the nervous system85-88 and innervation and 
vascularization are likely connected. It has been shown that axons penetrate the graft 
in close association with the ingrowing blood vessels81-83. Therefore, we cannot study 
islet reinnervation without concomitantly addressing vascularization processes.  
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Revascularization of islets of different species has been extensively studied in iso-, 
allo- and xeno-transplantation settings89-91. Parameters including vasculature density, 
blood flow, capillary branching index and oxygen tension revealed differences in the 
dynamics and efficiency of the revascularization process depending on the 
transplantation sites92-97. The time to restore normoglycemia and glucose tolerance can 
serve as functional readouts of islet revascularization in transplanted mice66,95,98. 
Several components are implicated in blood vessel formation including vascular 
endothelial growth factor (VEGF) 94,95,99-101. Islets secrete VEGF102, which can 
partially explain the rapid revascularization of transplanted islets. However, other cell 
types are also crucial for vessel formation. Recently, neutrophils have been implicated 
in the functional restoration of intraislet blood perfusion after transplantation101.  
It also has been shown that donor islet endothelial cells (DIEC) survive the 
transplantation procedure and form a functional part of the revascularized islet 
graft65,66,103. Sustaining DIEC before and after transplantation may not only facilitate 
the islet revascularization but may also recreate the original microvasculature 
environment with the appropriate signals allowing a proper reinnervation process.    
	
The collective evidence presented shows that there is a need to identify the innervation 
patterns and their functional roles in mouse and human islets. Four important 
observations have to be considered: 1) Autonomic activation plays a major role in 
glucagon secretion in animals52,104-107 but not in humans54-58,107-113; 2) humans have a 
smaller cephalic-phase insulin response than animals7,114; 3) patients subjected  to 
pancreas transplantation remain euglycemic without therapy 48-50,110; and 4) acute 
insulin responses to intravenous glucose in patients with chronic high cervical cord 
transaction are not altered115.  
 
We therefore formulated the central hypothesis that mouse islets are heavily dependent 
on nervous input, whereas human islets regulate hormone secretion almost 
autonomously using paracrine and autocrine mechanisms. 
 
However, we would like to emphasize that this hypothesis does not preclude the 
involvement of autonomic and intraislet (paracrine and autocrine) signals in islet 
function.  Rather, it states that the relative role of these components varies with the 
species and that human islets may rely more on intraislet signaling.  This view is in 
line with recent results showing a human islet cytoarchitecture that predisposes islet 
cells for paracrine signaling28,29 and new glutamate and ATP positive autocrine 
feedback loops in human alpha and beta cells116,117.   
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
Identify species differences in the innervation patterns of mouse and human pancreatic 
islets that might explain the discrepancy in the role of the autonomic innervation in 
islet function for both species 
 
Look for unidentified intraislet paracrine or autocrine signaling mechanisms 
supporting the functional independence of human islet of Langerhans from the 
autonomous nervous system 
 
Establish that intraocular islet grafts orchestrate the engraftment process to restore 
their native morpho-physiological environment by studying the processes of 
reinnervation and revascularization 
 
Investigate and manipulate the role of neural input on glucose homeostasis in vivo 
using mouse and human islet transplantation in the eye as a suitable experimental 
platform in a living organism 
 
Explore the potential of the transplantation into the eye to answer “state of the art” 
questions or needs. In this thesis, we examine the potential of the model to study 
dynamic behaviour of immune cells to be able to ultimately explore the claimed 
pathophysiological link between sensory fibers and autoimmune diabetes. We further 
evaluate the eye as a site for therapeutic implantation of islets in a relevant preclinical 
animal model 
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	


Human pancreata were obtained from multiorgan donors (n = 15, ages 18–63). Mice 
(C57BL/6, 129x1, NOD and Balb/c; n = 6 (per strain); 6 weeks old; three male and 
three female) were killed by exposure to a rising concentration of CO2, followed by 
cervical dislocation. All experimental protocols were approved by the University of 
Miami Care and Use Committee. We obtained tissue samples of human pancreata 
procured locally for islet transplantation from heart-beating organ donors (donation 
after cerebral death). These samples had ischemic times of <12 h. In addition, we 
obtained pancreatic tissue samples from biopsies performed in living donors. These 
samples were fixed in 4% PFA with no delay. All pancreas samples were trimmed to a 
volume smaller than 1 x 1 x 0.5 cm to ensure quick fixation. We obtained best results 
with biopsies from living donors (n = 2), but most of the other samples (11 out of 13) 
showed similar preservation of tissue structure and antigenicity. Most human tissue 
samples were as well-preserved as mouse tissue samples, as shown by the similar 
overall immunostaining patterns. 

Blocks of human or mouse pancreas (0.5 cm3) were fixed in 4% paraformaldehyde for 
4 h, cryoprotected in sucrose, and cut on a cryostat (40 μm). After a rinse with PBS-
Triton X-100 (0.3%), sections were incubated in blocking solution (PBS-Triton X-100 
and Universal Blocker Reagent; Biogenex, San Ramon, CA). Thereafter, sections were 
incubated 24 h (20oC) with primary antibodies diluted in blocking solution. To 
visualize the general innervation of the islet, we used antibodies against synapsin I/II 
(Synaptic Systems, Goettingen, Germany) or PGP 9.5 (Millipore, Billerica, MA). To 
label parasympathetic axons, we used antibodies against vAChT (Synaptic Systems) 
and choline acetyl transferase (ChAT; Millipore); to label sympathetic axons, we used 
antibodies against TH (Millipore) and vesicular monoamine transporter (vMAT; 
Synaptic Systems). In addition, we immunostained beta cells (insulin; Accurate 
Chemical & Scientific, Wesbury, NY), alpha cells (glucagon; Sigma, St. Louis, MO), 
delta cells (somatostatin; Serotec), endothelial cells (PECAM; BD Biosciences, San 
Jose, CA), and vascular myocytes (alpha smooth muscle actin [SMA; Sigma] or cell 
surface chondroitin sulfate proteoglycan neuron-glial 2 [NG-2; Millipore]). The 
antibodies used and their immunostaining patterns in the pancreas are summarized in 
Table 1. Immunostaining was visualized by using Alexa Fluor conjugated secondary 
antibodies (1:500 in PBS; 12 h at 20oC; Invitrogen, Carlsbad, CA). Cell nuclei were 
stained with DAPI. Slides were mounted with ProLong Anti Fade (Invitrogen). In 
control experiments, primary antibodies were incubated with corresponding control 
peptides (50 μg antigenic peptide to 1 μg antibody for 5 h). If peptide preadsorption 
was not possible (e.g., control peptides were not available for all antibodies used), we 
examined if the immunostaining for cell markers was tissue specific or cell specific, 
that is, if it corresponded to well-known staining patterns (e.g., TH-labeled axons 
around SMA-labeled blood vessels). The axonal and vascular staining patterns were  
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similar in the exocrine tissue in human and mouse pancreas, ruling out problems with 
antibody penetration, tissue preservation, and species cross-reactivity of the antibodies. 
Furthermore, we performed experiments with mouse tissues to mimic conditions of 
human pancreas handling. To rule out false negative results in the human tissue, our 
approach consisted of (1) using several antibodies for each axonal marker, (2) 
examining more than ten human pancreata for each antibody, (3) providing positive 
control staining in regions adjacent to the islet, and (4) mimicking human tissue 
handling conditions in mouse pancreas tissues. Results were only presented in the 
manuscript if the labeling pattern was consistent for most human pancreata inspected, 
if the overall staining pattern in pancreatic tissues (e.g. arteries, acini, nerves) was 
similar in human and mouse pancreata, and if the staining in mouse pancreas 
withstood the conditions under which human pancreata were processed. 
		

Confocal images (pinhole = airy 1) of randomly selected islets (three islets per section, 
minimum three sections per mouse or human) were acquired on a confocal laser 
scanning microscope (Leica SP5) with a 63x objective at 1024 x 1024 pixel resolution. 
The nerve fiber plexus was reconstructed in 3D stacks of images (step size = 0.7 μm) 
and analyzed using Leica or Volocity software. Using confocal images, we established 
whether an individual axon contacted a particular cell by using these criteria: (1) the 
contacted cell should have clear cytoplasmic staining and the nucleus should be 
visible; (2) fibers should be thin, elongated, and strongly stained; and (3) the nerve 
fiber must contact the cytoplasm of a cell (as defined in 1) in three-dimensional planes. 
The proportion of contacted cells was expressed as a percentage of the total number of 
cells of the same type. In addition, we used an automated method to quantify these 
contacts (see below). 
	
	  	

Axon immunostaining was analyzed and quantified in Z stacks (40 μm) of confocal 
images using Volocity software. We developed a macro in Volocity that automatically 
detected all the immunostained elements (in voxels) within a predefined volume (e.g., 
islet). The volume of immunostained elements is then expressed as a fraction of the 
examined islet volume. Using this macro, we calculated the fraction (i.e., density) of 
immunostained axons in mouse and human islets (Figure 1 A,B,C). We further used 
Volocity to quantify contacts between axons and islet cells. We developed a macro 
that automatically detects the ‘‘intersect’’ (i.e., proximity) between the 
immunostaining for axons and that for islet cells. The incidence of these nerve fiber-
cell contacts was expressed as the fraction of the total volume of detected 
intersects/total volume of cell immunostaining, which gave us the innervation density 
(i.e., contact density) of a particular cell type (Figure 1 D,E,F). The overlap of vAChT 
immunostaining with synapsin immunostaining was quantified using the ‘‘intersect’’ 
macro described above. This allowed us to determine the volume of axonal vAChT 
staining as opposed to cellular vAChT staining. The volume of axonal vAChT staining 
was then expressed as the fraction of the examined tissue volume. We further 
quantified the fractions of synapsin-labeled axons that were also labeled for vAChT or 
TH (volume of detected double staining/volume of synapsin immunostaining). 
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Figure 1.  Representation of axon density and contact density quantification 
(A) Three dimensional rendering of a z-stack of confocal images (n = 40) of a 
mouse pancreatic section stained for TH (green), glucagon (red), and DAPI 
(blue). (B) Islet volume (in voxels) is determined by outlining the islet using DAPI 
staining.  The volume of axonal staining is determined within this islet volume.  
(C) The axon (innervation) density is calculated as the quotient axon volume/ islet 
volume.  (D) TH-labeled axons can be seen in close proximity to glucagon-labeled 
alpha cells.  Shown is a higher magnification and rotated image of the islet in A.  
The proximity of axons to target cells can be detected using an algorithm in 
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Volocity software (“intersect).  Intersect between axons and cells is shown in 
yellow.  Notice that few axonal varicosities contact target cells (yellow and green 
overlap in the merged image on the right).  (E) Cellular (cell) volume is 
determined based on cell immunostaining, intersect volume is determined as the 
close proximity or overlap of axon and cell immunostaining.  (F) The contact 
density is calculated as the quotient intersect volume/ cellular volume. 
 
 

Human pancreata were obtained from heart-beating organ donors (donation after 
cerebral death).  Islets from human pancreata were isolated at the Human Islet Cell 
Processing Facility of the Cell Transplant Center at the Miller School of Medicine, 
University of Miami.  The glands were cold preserved in University of Wisconsin 
solution.  Islets were isolated using a modification of the automated method using 
seven different lots of the enzyme Liberase HI (Roche, Indianapolis, IN) and a 
standard purification step, as described previously118.  Human islet isolations were 
performed weekly at the Diabetes Research Institute.  C57BL/6 mice were killed by 
exsanguination under general anesthesia.  Mouse islet isolation is performed using 
collagenase digestion followed by purification on density gradients119. 
 


Our laboratory has developed a high-capacity, automated perifusion system (Biorep® 
Perifusion V2.0.0) to dynamically measure hormone secretion from pancreatic 
islets120.  In this system, a low pulsatility peristaltic pump pushes HEPES-buffered 
solution (100 µL/min) through a sample container harboring 100 pancreatic islets 
immobilized in Bio-Gel P-4 Gel (BioRad, Hercules, CA).  Glucose concentration was 
adjusted to 3 mM or 11 mM.  Stimuli were applied with the perifusion solution.  The 
perifusate was collected in an automatic fraction collector designed for a multi-well 
plate format.  The sample container harboring the islets and the perifusion solutions 
were kept at 37ºC in a built-in temperature controlled chamber, and the perifusate in 
the collecting plate was kept at < 4ºC, to preserve the integrity of the analytes in the 
perifusate. Perifusates were collected every minute.  Hormone release in the perifusate 
was determined with the human or mouse Endocrine LINCOplex Kit following 
manufacturer’s instructions (Linco research, St. Charles, MO).  The biomolecular 
assays were performed on a Bio-Plex protein array system (Bio-Rad, Hercules, CA).  
This system is a flow-based dual laser system that simultaneously identifies and 
quantifies up to 100 different analytes in a single assay. 




 
Thirty to three hundred isolated islets were transferred from culture media to sterile 
PBS and aspirated into a 27G eye cannula (27 gauge anterior chamber cannula; Katena 
Products, Inc., Denville, NJ) connected to a 1 ml Hamilton syringe (Hamilton, Reno, 
NV) via a 0.4 mm polythene tubing (Portex Limited, Kent, England). Athymic nude 
mice were anesthetized with an intramuscular administration of ketamine 
hydrochloride (42.8 mg/kg; Fort Dodge Animal Health, Fort Dodge, IA), xylazine (8.5 
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mg/kg; Phoenix Scientific, Inc., St. Joseph, MO), and acepromazine (1.4 mg/kg; 
Phoenix Scientific, Inc.).  A topical anesthetic was also applied (proparacaine 
hydrochloride eye ophthalmic solution).  Eyes were kept humidified (ophthalmologic 
eye drops) to avoid drying of the cornea.  The cornea may otherwise become opaque.  
Under a stereomicroscope, the cornea was punctured close to the sclera at the bottom 
part of the eye with a 27G needle. Care was taken not to damage the iris and to avoid 
bleeding. The blunt eye cannula was gently inserted, and the islets were slowly 
injected into the anterior chamber where they settle on the iris. After injection, the 
cannula was carefully withdrawn and the animal was left lying on the side before 
awakening.  Mice were then put back in the cages and monitored until full recovery, 
and observed daily thereafter.  Analgesia was obtained after surgical procedures with 
buprenorphine (0.05-0.1 mg/kg s.c.). 
 
Transplanted animals were anesthetized with a 40% oxygen and ~2% isoflurane 
mixture, placed on a heating pad.  The head was restrained with a stereotaxic 
headholder (SG-4N, Narishige, Tokyo, Japan) and positioned with the eye containing 
the engrafted islets facing up. The eyelid was carefully pulled back and the eye was 
gently held at the corneoscleral junction with a pair of tweezers attached to a UST-2 
Solid Universal Joint (Narishige). The tips of the tweezers were covered with a single 
piece of polythene tubing creating a loop between the two tips. This arrangement 
permitted a flexible but stable fixation of the head and eye without causing damage or 
disrupting the blood circulation in the eye. For fluorescence confocal imaging, an 
upright Leica DMLFSA microscope equipped with a TCS-SP5-AOBS confocal 
scanner (Leica Microsystems Heidelberg GmbH, Mannheim, Germany) and lasers for 
one- and two-photon excitation were used for imaging together with long distance 
water-dipping lenses (Leica HXC APO 10x 0.3W, 20x 0.5 W, 40x 0.8W and 63x 
0.9W), using filtered saline solution as an immersion liquid.  Widefield 
epifluorescence imaging was performed on the same microscope setup using an 
imaging system with a Xenon arc lamp for excitation, intensified CCD camera for 
detection, and motorized filter wheels for excitation and emission wavelength 
selection.  Two-photon excitation was achieved using a tunable, femto-second 
Ti:Sapphire laser (Chameleon Ultra II, Coherent Inc., Santa Clara, CA) and emission 
light was collected and separated onto two non-descanned detectors.  Other 
fluorophores were excited with their appropriate one- or two-photon wavelengths.  In 
two-photon imaging, GFP and Texas Red were excited at 890 nm and emission light 
was collected and separated onto two non-descanned detectors using a dicroic mirror 
(RSP560) and emission filters (BP 525/50 and BP 640/20).  The images captured with 
TPLSM were denoised using wavelet filtering.  In one photon imaging, GFP is excited 
at 488 nm (35% AOTF) and emission light was collected between 495-530 nm.  
Reflected light was imaged by illumination at 546 nm (35% AOTF) and collection 
between 539-547 nm.  Post-processing, analysis, and visualization of images were 
performed with a number of software tools including: Leica Confocal Software, Andor 
iQ software, Volocity (Coventry, UK), and Image J (NIH, USA). 
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Mouse (C57BL/6) pancreatic islets were isolated as described above. Diabetes was 
induced in athymic nude mice with a single intravenous injection of streptozotocin 
(200 mg/kg; Sigma, MO). To ensure that endogenous beta cells have been eliminated, 
only animals with nonfasting glycemic values >350 mg/dl were used. We transplanted 
300-400 islet equivalents into the anterior chamber of the right eye of the mice. This 
provides an optimal beta-cell mass that we normally apply in the syngeneic 
transplantation setting either in the eye or under the kidney capsule.  We ensured that 
the islets were evenly distributed across the iris.  To avoid reflux of islets out of the 
anterior chamber, we let the intraocular pressure subside by waiting 10-20 seconds 
with the cannula in place and then resuming the injection.  Thus, the 300-400 islet 
equivalents were injected in individual thrusts of 50-100 islets over 3 minutes. During 
the peritransplantation period mice were supported with insulin pellets or insulin 
injections.  The procedure for human islets was different because approximately 1,000 
human islet equivalents need to be transplanted to reverse diabetes in mice.  We 
therefore transplanted both mouse eyes, with each eye receiving 500 human islet 
equivalents.  Plasma glucose levels were monitored daily after transplantation.  We 
considered transplantation successful and islet grafts functional once recipient mice 
reached glycemic values below 200 mg/dl. Our success rate for mouse to mouse 
transplantation was >90% and for human to mouse it was ~50% (human islet 
preparations are highly variable in terms of quality).  Mice that did not revert to 
normoglycemia were not included in the studies. 

We monitored graft function by measuring nonfasting glycemia using a portable 
glucometer (OneTouch, LifeScan). We define normoglycemia as nonfasting blood 
glucose below 200 mg/dl. We performed glucose tolerance tests after 12–16 h of 
fasting by measuring glycemic values on peripheral blood following intraperitoneal 
injection of 2 g/kg glucose in saline for mouse transplanted with mouse islets or 4 g/kg 
for those mice transplanted with human islets and the respective control animals. Tail 
blood samples (50 μl) were taken before the start of the experiment and at 0, 3, 10, and 
30 min for determination of plasma glucagon and insulin secretion. Hormone plasma 
levels was determined with the human or mouse Endocrine LINCOplex Kit following 
manufacturer’s instructions (Linco research, St. Charles, MO). The biomolecular 
assays were performed on a Bio-Plex protein array system (Bio-Rad, Hercules, CA).  
To exclude residual function of the native pancreas we removed the graft-bearing eye 
(enucleation) under general anesthesia (ketamine/xylazine) and followed the glycemia 
values for 2 days. 
 
Paper I. All data were presented as mean ± SEM.  For statistical comparisons of 
innervation densities and axons-endocrine cell contacts we used one-way ANOVA 
followed by multiple comparisons (Student-Newman-Keuls). Student’s t test was used 
to compare the density of cholinergic axons and smooth muscle actin contents. 
Paper II. All data were presented as mean ± SEM. Association between vAChT and 
ChAT mRNA levels was assessed by linear regression. Colocalization of subcellular 
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staining was done by Pearson’s correlation coefficient comparison by ANOVA 
followed by multiple comparisons. Biosensor Ca2+ responses and fluorescence assay 
data to estimate ACh secretion were compared by ANOVA followed by multiple 
comparisons. Pharmacological data showing that endogenous release of ACh amplifies 
glucose-induced insulin secretion were analyzed with Student’s t tests for single 
comparisons for every particular drug as detailed in the results section of the paper. 
Paper III. Biosensor Ca2+ responses to estimate ACh secretion were compared by 
ANOVA followed by multiple comparisons (Student-Newman-Keuls). The 
differences between mouse and human islets in their ACh secretory profiles were 
tested by Fisher’s exact test.  
Paper IV, V, VI, VII and VIII. All data were presented as mean ± SEM. Differences in 
glycemia values and IPGTT were tested by ANOVA followed by multiple 
comparisons. 
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Innervation patterns of autonomic axons in the human endocrine 
pancreas 
The endocrine pancreas is innervated by the autonomic nervous system, but the 
abundance and organization of this innervation are highly variable between species6.  
Several nerve fiber systems have been described for islets of different species using 
immunohistochemistry11,17,121-125.  Receptors for autonomic neurotransmitters are 
expressed on the plasma membrane of islet cells, and it is known that these 
neurotransmitters modulate islet hormone secretion5,23.  It is difficult, however, to 
obtain a coherent picture from the literature.  There are no comprehensive studies that 
examine all innervation patterns and their targets in a single species.  Comparisons 
between species are not possible because common techniques or markers have not 
been used.  It is important to remember that most of the studies have been conducted 
on rodent islets and that few studies have examined the autonomic innervation and its 
effects in human islet cells.  Because the cell composition and cytoarchitecture are 
different in rodent and human islets 28,29, it is very likely that the innervation patterns 
also differ.   
 
This paper reassesses the innervation patterns in mouse and human islets by testing the 
working hypothesis that there are qualitative differences in the innervation patterns 
between mouse and human islets.   
 
The experimental approach consisted of identifying the parasympathetic and 
sympathetic components of the innervation, as well as their cellular targets in the islet 
using immunohistochemistry on thick human and mouse pancreatic sections. As 
putative targets we examined alpha, beta, and delta cells, as well as endothelial and 
smooth muscle cells of the blood vessels.  The nerve fiber plexus was reconstructed 
and analyzed in 3D stacks of images. We examined pancreatic tissues from 24 mice of 
different strains and 15 human biopsies from pancreas donations for islet isolation. 
 
We found that, compared to mouse islets, human islets were sparsely innervated with 
most markers tested. In mouse islets, sympathetic fibers (TH) and parasympathetic 
fibers (vAChT) form a dense plexus in the islet periphery and core, respectively. In the 
human pancreas, neural fibers can be seen in the exocrine tissue, but only few 
penetrate the islets.  Similar results were obtained with additional parasympathetic 
(ChAT), sympathetic (vMAT) and axonal markers (PGP 9.5, acetylated α-tubulin, 
Neurofilament 200 and synapsin). Immunostaining for the autonomic markers was 
very similar in nerves, major vessels and the exocrine tissue surrounding the islets in 
human and mouse pancreata, indicating that the observed differences were selective 
for the islets.  
 
The results showed that most axons innervating human islets are sympathetic.  Out of 
the total axonal labeling in the islets, few were reactive for vAChT. Instead, much of 
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the vAChT staining colocalized with glucagon. By contrast, TH-labeled axons in 
human islets were present in the core.  
 
Characterization of the sympathetic innervation in human islets revealed that 
sympathetic axons barely innervate endocrine cells. This result was strikingly different 
to the pattern of sympathetic innervation within the mouse islets, where TH-labeled 
axons contacted glucagon labeled alpha cells or somatostatin-labeled delta cells. 
Because the sympathetic axons were localized in regions devoid of endocrine cells we 
examined vascular cells as potential targets of sympathetic axons. We observed that 
TH-labeled axons in human islets traveled along the vessels, ran parallel to PECAM-
labeled endothelial cells, and contacted cells stained for smooth muscle actin (SMA).  
Thus the contractile cells of blood vessels in the human islets were the major targets of 
sympathetic innervation. The content of intraislet smooth muscle cells was much 
higher in human islets than in mouse islets. 
 
In summary, by visualizing axons in three dimensions and quantifying axonal densities 
and contacts within pancreatic islets, we found that, unlike mouse endocrine cells, 
human endocrine cells are sparsely contacted by autonomic axons. The invading 
sympathetic fibers preferentially innervate smooth muscle cells of blood vessels 
located within the islet. Thus, rather than modulating endocrine cell function directly, 
sympathetic nerves may regulate hormone secretion in human islets by controlling 
local blood flow or by acting on islet regions located downstream. 
 
These findings are important because they demonstrate that it is problematic to 
extrapolate knowledge from mouse studies to humans.  The results further suggest that 
innervation may have a strong influence on mouse islet function; it is however unclear 
how the sparse innervation in human islets should contribute to hormone secretion 
since parasympathetic and sympathetic fibers do not seem to innervate endocrine 
targets in human islets. This morphological discrepancy correlates to many of the 
physiological incongruities reported in the literature regarding the influence of 
autonomic innervation on human glucose homeostasis with respect to other species. 
Figure 2.  Compared to mouse, human endocrine cells are sparsely contacted by 
sympathetic and parasympathetic axons. Human intraislet smooth muscle cells of 
the vasculature are targets of sympathetic innervation. 
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		
Alpha cells secrete acetylcholine as non-neuronal paracrine signal 
priming beta cell function in humans 
Acetylcholine is a neurotransmitter that plays a major role in the function of the insulin 
secreting pancreatic beta cell6,21. It is generally believed that the human endocrine 
pancreas is richly innervated by the autonomic nervous system3,5,6,126 and that 
acetylcholine is released from parasympathetic nerve endings in pancreatic islets 
during feeding5,6. Parasympathetic innervation of the islets of Langerhans has been 
shown to provide cholinergic input to the beta cell in several species13,15,16,127, but the 
role of autonomic innervation in human beta cell function is at present unclear. In 
paper I we showed that endocrine cells of the human islet receive little autonomic 
input. These findings are not consistent with the current view that the autonomic 
nervous system controls insulin secretion via parasympathetic fibers. Intriguingly, we 
observed that the cholinergic marker vAChT was consistently co-expressed with 
glucagon in alpha cells. Given the unique cellular arrangement of human islets, where 
most beta cells (70-80%) face alpha cells29,128, it is conceivable that paracrine 
acetylcholine signaling occurs. Human alpha cells seem optimally placed to influence 
beta cells. 
 
In this paper we put forward the new notion that human islets are less dependent of 
neural cholinergic input than mouse islets. We therefore tested the working hypothesis 
that acetylcholine is a paracrine signal in human islets, which is activated under 
circumstances that cannot be modeled with rodent studies. 
 
We reassessed the presence of cholinergic markers in mouse and human islets.  Using 
immunohistochemistry on human and mouse pancreatic sections we confirmed that, in 
contrast to mouse islets, human islets are scarcely innervated by cholinergic (vAChT-
immunoreactive) parasympathetic nerve fibers. Instead, most human alpha cells were 
strongly vAChT and ChAT immunoreactive. The presence of vAChT, ChAT and 
ChT1 in isolated, denervated human islets was confirmed by Western blot analysis and 
mRNA expression analysis consistently showing that these cholinergic genes were 
expressed in the human islets with comparable or higher levels than in the brain. 
 
Within the alpha cell, vAChT staining did not overlap with glucagon staining and 
appeared confined to distinct subcellular compartments. This agrees with studies 
showing that, in neuroendocrine cells, vAChT localizes preferentially in synaptic-like 
vesicles and is excluded from hormone granules.  To strengthen this observation, we 
used STED microscopy imaging of similarly stained pancreatic sections after the 
publication of this paper.  Our findings support our published results (Figure 3).  That 
vAChT is localized in vesicles other than glucagon granules, however, needs to be 
confirmed by electron microscopy studies.  
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Figure 3.  Human pancreatic alpha cells stained for glucagon (red) and vAChT 
(green) were visualized by STED microscopy at 60 nm of resolution (left panel). 
Glucagon granules and vAChT reactive structures are depicted in higher 
magnification (right panel). 
 
 
After demonstrating that human alpha cells have the machinery for the exocytosis of 
acetylcholine, we tested if and when they secrete it using acetylcholine biosensor cells. 
We found that human islets release acetylcholine when stimulated with kainate or a 
lowering in glucose concentration, two specific stimuli for alpha cells. Thus, in 
marked contrast to the parasympathetic cholinergic control of insulin secretion 
described for rodents and other species, alpha cells of the human islet may provide 
paracrine cholinergic input to surrounding endocrine cells. 
 
To infer the role of acetylcholine as a paracrine signal, we subjected isolated human 
islets to an experimental protocol in which beta cells and alpha cells were stimulated 
intermittently while modulating the intrinsic cholinergic signaling. Blocking 
acetylcholine degradation with the acetylcholinesterase blocker physostigmine 
increased insulin release during repeated exposure to high glucose (11 mM), whereas 
adding the M3 receptor-specific antagonist J-104129 reduced insulin responses. Thus, 
in the absence of any influence from the autonomic nervous system, endogenously 
released acetylcholine in human islets is able to sensitize the beta cell to subsequent 
increases in glucose concentration. 
 
Our results demonstrate that human alpha cells secrete acetylcholine, the major 
parasympathetic neurotransmitter, as a paracrine signal that primes the beta cell to 
respond optimally to subsequent increases in glucose concentration. The nature of 
acetylcholine as a paracrine signal and not only a neural signal as in rodents, further 
implies that cholinergic signaling in the human endocrine pancreas is activated under 
circumstances that cannot be predicted from rodent studies, highlighting the 
importance of species divergence in the pancreatic islet. We anticipate these results to 
revise models about neural input and cholinergic signaling in the human endocrine 
pancreas. 
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Figure 4.  Human islets of Langerhans are less dependent on neural acetylcholine 
than mouse islets. Acetylcholine, the major parasympathetic neurotransmitter, is 
secreted as a paracrine signal by human alpha cells and primes beta cells for an 
optimal response to glucose.  
 
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Real time detection of acetylcholine release from the human 
endocrine pancreas 
Acetylcholine was the first neurotransmitter to be characterized. It is the main 
neurotransmitter in muscular synapses and plays an important role in the central 
nervous system associated with attention, memory, learning, consciousness, sleep and 
control of voluntary movements129. However, the lack of simple methods to detect its 
secretion has limited studies where acetylcholine plays an important role, since 
estimating acetylcholine is fraught with difficulties related to selectivity, temporal and 
spatial resolution, and the rapid degradation of the molecule130. Techniques most 
commonly used include dual enzyme biosensors131-134, electrochemical 
detection129,135,136 and liquid chromatography/mass spectrometry136-139. The application 
of all these methods demands the investment in expensive and sophisticated equipment 
and highly specialized expertise of the personnel. In fact, the actual determination of 
acetylcholine release from human islet endocrine cells became the most challenging 
approach to evaluate that acetylcholine is a paracrine signal in human islets, which was 
the working hypothesis of paper II. We were able to record acetylcholine release from 
human pancreatic islets by applying a relatively simple and inexpensive approach 
using acetylcholine biosensors cells. 
 
In this paper we describe a simple protocol, which allowed us to detect the release of 
the neurotransmitter acetylcholine from pancreatic human islets. Our aim was to show 
the advantages and simplicity of a method that can be easily applied to studies with 
other neurotransmitters without all the intrinsic technological and practical limitations 
associated with other methods. 
 
In this protocol, we describe the use of biosensor cells to detect neurotransmitter 
release from endocrine cells in real time. CHO cells expressing the muscarinic 
acetylcholine receptor M3 were used as acetylcholine biosensors to record 
acetylcholine release from human pancreatic islets. We show how acetylcholine 
biosensors loaded with the Ca2+ indicator Fura-2 and put in close contact to isolated 
human pancreatic islets allow detection of acetylcholine release. We found that Ca2+ 
responses in biosensor cells could be evoked under conditions that stimulate human 
alpha cells but not beta cells.  By contrast, we could not measure acetylcholine 
secretion from mouse islets.  This led us to conclude that human alpha cells secrete 
acetylcholine.  
 
The biosensor approach is simple. The Ca2+ signals generated in the biosensor cell 
reflect the presence (release) of neurotransmitter. The procedure has great sensitivity 
and temporal resolution because it detects the neurotransmitter near to its release site. 
A major limitation is that the technique is qualitative and results from different 
experiments cannot be compared quantitatively. Individual biosensor cells may have 
different sensitivities to the neurotransmitter. As with all microscopic approaches, the 
biosensor technique is also affected by spatial constraints such as distance and access 
to the release sites. 
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Biosensor cells are readily accessible. For instance, CHO cells stably expressing a 
wide variety of different transmitter receptors are commercially available and easily 
maintained in the laboratory, making these cells biosensors of choice for many 
applications. Furthermore, biosensor cells can be designed to express a combination of 
receptors to demonstrate co-release of neurotransmitters. Thus, the protocol can be 
used to define the secretory phenotype of cells in other tissues. 
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A simple noninvasive system for investigating the role of innervation 
in pancreatic islet function in vivo 
Numerous studies have shown that the endocrine pancreas is richly innervated by the 
autonomic nervous system3-7. The role of islet innervation in the maintenance of 
glucose homeostasis is still poorly understood since autonomic input on islet 
physiology cannot be studied in vivo. There are no reliable methods for functional 
monitoring islet innervation due to the lack of experimental tools. The eye has long 
been used to study the mechanisms of reinnervation of tissue grafts, including 
pancreas, and the behavior of intrinsic nerves71,72,74,140-149. Human brain and heart 
xenografts have been shown to survive for at least 15 months in the eye and the human 
grafts were functionally innervated by the autonomic nerve fibers of the host rat 
iris72,75-77. Moreover, studies have shown that iris sympathetic fibers establish 
functional connections in intraocular brain grafts similar to the synapses normally 
formed in situ150,151. Islets are reinnervated after transplantation, both in the eye84 and 
elsewhere81-83,152. Independently of the transplantation site, the innervation pattern of 
the islet grafts seems to differ only slightly from that of pancreatic islets in situ83,153. 
The density of innervation, however, depends on the transplantation site. Islets 
transplanted under the kidney capsule are more densely innervated than islet grafts in 
the spleen and liver82, indicating that the host organ shapes the reinnervation density of 
the islet graft. If so, the highly innervated iris is an ideal transplantation site for 
reinnervation of the islets.  
 
To specifically study the effects of parasympathetic and sympathetic innervation on 
islet function we used a new experimental model allowing in vivo imaging of 
vascularized and reinnervated islets. Mouse islets were transplanted into the eye and 
their function was recorded locally and systemically after manipulation of the eye's 
neural input. The goal was to establish an experimental platform that ultimately allows 
us to investigate the role of innervation on human islet function in vivo. 
 
We first examined the time course of the reinnervation process and the extent to which 
the incoming fibers are of the appropriate type and whether they innervate the correct 
targets in intraocular islet grafts. Immunostaining showed growing fibers traveling first 
along blood vessels and then turning to their endocrine targets. Intraocular islet grafts 
were strongly innervated 90 days after transplantation in a pattern that closely 
resembled that of the native pancreas (Figure 5). It is important to state that the 
intraocular islet grafts might not be under the control of the autonomic nervous system 
as they are in the pancreas.  The sympathetic and parasympathetic fibers in the eye are 
not likely to receive input from the brain regions regulating islet function; they are part 
of the circuits regulating pupillary size.  However, endocrine cells in intraocular islet 
grafts attract fibers similar to the ones that innervate them in the pancreas. 
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Figure 5.  Mouse islets of Langerhans transplanted into the mouse eye are 
reinnervated with sensory fibers. Z-stack of confocal images of an intraocular 
islet graft showing sensory fibers reactive for CGRP and substance P antibody 
cocktail (green) and glucagon positive cells (red). Cell nuclei were counter-stained 
with DAPI (blue). 
 
 
To image cholinergic fibers noninvasively, we transplanted islets into the eyes of mice 
expressing GFP under the control of the ChAT promoter.  GFP-labeled, cholinergic 
axons and cell bodies of the neuroinsular complex could be seen associated both with 
the intraocular islet grafts and with pancreatic islets in sections from ChAT-GFP mice. 
This confirms that islets are similarly innervated in the native pancreas and after 
transplantation into the eye.  The results show the feasibility of in vivo tracing of 
autonomic fibers using mice with GFP-labeled axons. In future studies, we will 
visualize plastic changes in the cholinergic innervation under physiological and 
pathophysiological conditions (e.g. diabetic neuropathy). 
 
 
Having established that the islet innervation patterns after transplantation were 
appropriate, our model allowed a detailed dissection of the role innervation has on islet 
function in vivo.  One feature of intraocular grafts is that their autonomic input can be 
regulated by light via the pupillary reflex. Given that light increases cholinergic input 
to the iris to constrict the pupil, while noradrenergic fibers are activated in the dark to 
dilate it, we expected that intraocular islets grafts secrete more insulin in ambient light 
compared to darkness.  Indeed lower values of fed glycemia, higher plasma insulin 
levels and improved glucose excursion after IPGTT under light conditions confirmed 
our prediction. This indicated that light modulates islet graft function in the eye.   
 
The eye has the great advantage that drugs can be applied locally in a noninvasive 
manner.  Eye drops containing autonomic drugs are commonly and routinely used in 
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the ophthalmic clinic. We tested if islet graft function, as measured by glucose 
tolerance tests, could be modulated directly with known autonomic modulators of islet 
function. Topical application of pilocarpine, a muscarinic agonist, improved glucose 
tolerance. By contrast, applying atropine, a muscarinic antagonist, partially inhibited 
the effects of light stimulation, indicating cholinergic mechanisms. These data are 
important because they show that with our model it is feasible to manipulate 
autonomic input noninvasively. 
 
It has been shown that various mouse strains differ in their glucose tolerance and 
threshold glucose concentration for 1st phase insulin release, with 129x1 mice 
exhibiting lower blood glucose levels than C57BL/6 mice154. In earlier studies we 
found that C57BL/6 mouse islets have a higher density of parasympathetic innervation 
than 129x1. By using the eye imaging platform, we tested the hypothesis that the 
different sensitivities to glucose are related to their different degrees of 
parasympathetic innervation. We transplanted islets from both mouse strains into the 
eye of two groups of nude mice and performed glucose tolerance tests in the dark and 
in ambient light to manipulate the cholinergic input to the islets grafts. We found that 
parasympathetic innervation had a great impact on islet function in C57BL/6 but not in 
129x1 mice, which might be related to the major difference in glucose homeostasis of 
both mouse strains. 
 
Our study shows the versatility and simplicity of our experimental platform which 
enables noninvasive, local, and selective manipulation of the nervous input while islet 
function is recorded locally or systemically in real time or longitudinally under 
physiological conditions. Similar studies can be performed in transplanted mice under 
diabetic conditions. 
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Donor islet endothelial cells in pancreatic islet revascularization 
Within the native islets, the nerves follow the blood vessels and terminate within the 
pericapillary space, within the capillary basement membrane, or closely apposed to the 
endocrine cells8 . Furthermore, glucose reaches endocrine islet cells in the native 
pancreas through the microvasculature. The vascular arrangement therefore surely has 
an impact on islet cell function. Transplanted islets are revascularized by blood vessels 
that grow into the islets from the host organ via angiogenesis, but donor islet 
endothelial cells (DIECs) can also form functional vessels within transplanted 
islets65,103. The contribution of DIECs in the process of revascularization is highly 
dependent on the time frame between islet isolation and their transplantation in the eye 
since most of the DIECs disappear if islets are cultured65,103,155. Therefore, it is 
important to determine the experimental conditions that contribute to establish an islet 
graft neovasculature that closely mimics that of islets in the pancreas. 
 
In this paper we further characterized islet transplantation into the eye as an 
experimental platform to study islet biology in vivo by testing the hypothesis that the 
neovasculature in transplanted islets resembles that of the islets in the native pancreas, 
independently of the origin of the endothelial cells in the process of revascularization. 
  
Freshly isolated mouse islets, which contain DIECs, and cultured mouse islets, which 
have lost DIECs, were transplanted under the kidney capsule and into the mouse eye. 
Intravital laser-scanning microscopy was used to monitor the revascularization process 
and DIECs in intact grafts. The grafts’ metabolic function was examined by reversal of 
diabetes, and the ultrastructural morphology by transmission electron microscopy. We 
used revascularization rate, vascular density, and endocrine graft function after 
transplantation of freshly isolated and cultured islets as parameters to infer how DIECs 
contribute to neovascularization and impact graft function. 
 
As previously reported65,103, DIECs significantly contributed to the neovasculature of 
fresh islet grafts and remained in the graft vasculature over long time periods. The 
early participation of DIECs in the revascularization process correlated with a faster 
revascularization rate of freshly isolated islets compared with cultured islets. However, 
after complete revascularization, the vascular density was similar in the two groups. 
Surprisingly, grafts originating from cultured islets reversed diabetes more rapidly 
than those originating from fresh islets. This result could be explained by other 
parameters like lowering the pro-inflammatory profile of the freshly isolated islet or 
selection of the most viable islets after culture. In addition, the high oxygen tension of 
the anterior chamber of the eye could have masked the advantage of a higher 
revascularization rate by reducing hypoxia during engraftment.  
 
One striking finding was that endothelial cells in intraocular islet grafts acquired the 
typical and native intraislet endothelial cell phenotype with thin cell bodies and 
abundant fenestrations. We could not find any morphological evidence that would 
suggest differences between host and donor endothelial cell ultrastructure.  
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It is conceivable that human DIECs will participate in the revascularization of human 
islet grafts in the eye of immune compromised mice, as reported in other sites of 
transplantation103, and therefore acquire their native intraislet ultrastructure.  Thus, 
functional human blood vessels may be reassembled in human xenografts in the mouse 
eye and persist for long times. This platform would enable physiological studies that 
recreate a vascular-endocrine environment connected to a living organism similar to 
the native human pancreas. 
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High-resolution, noninvasive longitudinal live imaging of immune 
responses 
We have previously shown that sensory fibers reinnervated mouse islets engrafted in 
the eye. Mouse sensory afferent neurons are a critical component in prediabetes 
initiation, promoting islet inflammation through altered glucose homeostasis and 
progressive beta cell stress45,156. Islet transplantation into the eye could be an excellent 
approach to dynamically evaluate the interface between the nervous and the immune 
system in the pathogenesis of autoimmune diabetes. 
 
In this study we evaluated the anterior chamber of the eye as an experimental platform 
to study the dynamic processes of the immune response in the mouse eye with the 
ultimate goal to further evaluate how sensory fibers are linked to the autoimmune 
responses driving diabetes.  
 
We noninvasively studied the in vivo dynamic behavior of green-fluorescent protein 
(GFP)-labeled T-lymphocytes in pancreatic islet allografts. MHC-mismatched DBA/2 
mouse islets were transplanted without immunosuppression into the eye of recipient 
mice expressing GFP in effector and memory T-lymphocytes. Longitudinal in vivo 
imaging revealed a progressive accumulation of GFP+ T-lymphocytes, which 
paralleled loss of volume/function of allogeneic islets.  
 
In vivo analysis of morphology and dynamic behavior of intraislet T-lymphocytes 
revealed a novel “ruffled” cell phenotype, which predominated during the effector 
phase of rejection. Ruffled cells extended pseudopodia in multiple directions 
simultaneously and engaged in contacts with other surrounding T-lymphocytes and 
target islet cells. The ruffled phenotype was characterized by a significantly increased 
but constrained dynamic behavior within the islet allografts, suggesting that cytotoxic 
T-lymphocytes engage in simultaneous contacts with multiple target cells ensuring 
effective killing during allorejection.  
 
We demonstrate that transplantation into the eye provides a versatile experimental tool 
that enables longitudinal, noninvasive in vivo imaging of immune responses within 
target tissues with cellular resolution. It is noteworthy, that these data demonstrate that 
the immune-privilege, which is transiently provided by this transplantation site, is 
broken following revascularization of the graft, and hence immune reactions are 
feasible to study. This process allows studying cell–cell interactions within target 
tissues and visualizing immune cell motility in situ.  By using our technological 
platform we can envisage studies extending beyond those that initially described the 
interactions between sensory axons and immune cells.  We will perform experiments 
in which sensory axons innervating intraocular islet grafts are manipulated in 
transplanted NOD mice, while monitoring changes in the immune cell infiltration and 
behavior. 
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The anterior chamber of the eye as a clinical transplantation site for 
the treatment of diabetes: a study in a baboon model of diabetes 
Pancreatic islet transplantation in patients with unstable type 1 diabetes has shown 
promise as a cure of the disease. Among the difficulties is the establishment of an 
appropriate transplantation site157-159. We have previously shown that transplanting 
pancreatic islets into the eye allowed for engraftment and adequate function along with 
noninvasive monitoring in mice59,60.  The eye as a transplantation site offers valuable 
advantages to be considered, including the claimed immune privilege properties and 
the immune-modulatory effects of the eye, the potential for noninvasive monitoring of 
the graft and local administration of drugs, e.g. immunosuppressant drugs. 
 
The aim of this study was to provide evidence that the eye can serve as a novel clinical 
islet implantation site using a preclinical non-human primate model. 
 
Allogeneic pancreatic islets were transplanted into the eye of a baboon model for 
diabetes, and metabolic and ophthalmological outcomes were assessed. Islets readily 
engrafted onto the iris along with a concomitant decrease in exogenous insulin 
requirements due to insulin secretion from the intraocular grafts.  HbA1C levels were 
reduced to near pre-diabetes levels. No major adverse effects on eye structure and 
function could be observed during the transplantation period. Our study demonstrates 
the long-term survival and function of allogeneic islets after transplantation into the 
eye.  
 
In this study, we provided a proof-of-concept that pancreatic islet transplantation into 
the eye of nonhuman primates significantly improves glycemic control and prevents 
serious hypoglycemic episodes in the recipient. The safety and simplicity of this 
procedure provides support for further studies aimed at translating this technology into 
the clinic.  Remaining questions include whether accomplishing complete insulin 
independence is feasible with islet transplantation into a single eye versus both eyes 
and whether the procedure interferes with vision. Addressing these questions will help 
advance the anterior chamber as a clinical transplantation site for pancreatic islets in 
the treatment of type 1 diabetes. 
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A new experimental platform to study human islet cell biology in vivo. 
The ultimate goal of this thesis was to establish an experimental model to evaluate the 
role of neural input on human glucose homeostasis in vivo. Unfortunately, functional 
imaging of human islets in situ remains challenging since non- or minimally-invasive 
technologies to monitor islet cell function are not fully developed. We used 
transplantation of human islets into the eye of immune-compromised mice as a 
platform to visualize and follow up the engraftment and function of human islets in a 
living organism. It is very likely that human islets engrafted in the iris of immune-
compromised mice retain their intrinsic nature and orchestrate the process of 
revascularization and reinnervation to reconstruct their natural environment (similar to 
the reinnervation observed for C57BL/6 and 129x1 transplanted islets in paper IV).  
 
In this paper, we have explored islet transplantation into the mouse eye as an 
experimental platform to study human islet biology in vivo.  Our aim was to establish a 
“humanized” mouse model in which human islets are maintaining glucose 
homeostasis. In view of the striking findings about human islet innervation and 
intraislet paracrine interactions described in paper I and II, this model may aid as a 
versatile tool to clarify the integration of complex signaling networks at the cellular 
level under in vivo conditions. With this platform, we can study the effects of 
modulatory inputs from hormonal and neuronal systems, as well as those of autocrine 
and paracrine signals of endocrine or vascular cells in the human islet of Langerhans.  
 
We performed immunohistochemical studies to visualize endocrine cells in 
histological sections of the mouse eye containing human islet grafts. Intraocular 
human islet graft cytoarchitecture and cell composition resembled those of human 
islets in the pancreas. We further examined human islet grafts with axonal markers and 
found that sympathetic axons could be seen traveling along blood vessels inside islet 
grafts. There was no parasympathetic innervation of the islet graft, and similar to the 
native human pancreas some endocrine cells expressed cholinergic markers.  These 
innervation patterns were similar to those of islets in the pancreas. Our results suggest 
that mouse and human islet grafts have the intrinsic capability to reproduce their 
endogenous innervation patterns in the eye.  The lack of innervation could also be 
explained by the species mismatch that does not allow mouse axons to penetrate 
human tissues.  These incompatibilities, however, can be ruled out because other 
human tissues have been successfully transplanted into the eye, where they become 
strongly and appropriately innervated72,75-77.  
 
We transplanted human islets into the eye of streptozotocin-treated athymic nude mice 
and the animals achieved and maintained normoglycemia for over 150 days. Human 
C-peptide and glucagon blood levels changed after 12h fasting or during IPGTT, 
indicating that function of intraocular islet grafts was regulated by glycemia. Our 
results indicate that human islets transplanted into the eye of immune-deficient mice 
engraft and are fully functional, achieving tight metabolic control.  
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Vasculature of human islet grafts in the eye was visualized by injection of fluorescein 
dextran. Islet neovascularization was completed within 30 days post-transplant and 
time to diabetes reversal paralleled the progression of vascularization. We further 
observed that blood flow in intraocular human islet grafts is highly regulated, as shown 
in time-lapse recordings of blood flow inside the intraocular human islet grafts.  The 
speed of red blood cells could be effectively estimated.  In addition, we visualized 
changes in regional vascular perfusion within the islet grafts that were most common 
at vessel bifurcations, suggesting that these might be sites of local blood flow 
regulation. 
 
Transplantation of human islets into the eye is a suitable tool to study human islets in 
the living organism.  With this approach, human islet biology can be studied at the 
cellular level and correlated with glucose homeostasis.  This will allow measuring the 
effects of modulatory compounds on human islet health and survival in vivo. Our 
results thus establish the basis for noninvasive in vivo investigations of complex 
cellular processes, like beta cell stimulus-response coupling, which can be performed 
longitudinally under both physiological and pathological conditions, along with beta 
cell survival and/or proliferation.  
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Autonomic innervation of pancreatic islets is qualitatively and quantitatively different 
between mice and human. The sparse innervation of human endocrine cells suggests 
that the autonomic nervous system does not contribute directly to hormone secretion 
as in mice.  
 
In contrast to mouse islets, human islets do not receive a dense parasympathetic nerve 
supply. Parasympathetic innervation may play an important role in mouse islet 
function but human islets are self reliant in terms of acetylcholine signaling. 
 
Human alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming 
beta cells. 
 
Sympathetic innervation may regulate human hormone secretion by controlling 
intraislet blood flow. 
 
Mouse and human intraocular islets grafts determine their own pattern of innervation. 
 
The study of the revascularization process in mouse intraocular islets grafts reveals 
that islets restore the features of the native vascular endothelium microenvironment 
independently of the origin of neovascularization. 
 
It is possible to manipulate the lineage of intraocular islet graft vasculature through 
interventions that activate, amplify, or sustain donor intraislet endothelial cells before 
and after transplantation. Thus, islets grafts can reinstate their native vascular-
endocrine microenvironment. 
 
The anterior chamber of the eye can be used as an experimental platform to investigate 
and manipulate the nervous input on islets and its effect on glucose metabolism. 
 
Transplantation of human islets into the mouse eye is a suitable method to study 
human islets in the living organism. 
 
Transplantation into the anterior chamber of the eye provides a versatile tool that 
enables longitudinal, noninvasive in vivo imaging of immune responses within target 
tissues with cellular resolution. 
 
The anterior chamber of the eye has therapeutic potential as a novel transplantation site 
to treat type 1 diabetes.  
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